The DCAT Pulse

The DCAT Pulse

About The DCAT Pulse

Developed by DCAT volunteer committees, The DCAT Pulse is a new, member-focused insights hub designed to grow and evolve as an essential resource for the DCAT community. This initiative delivers timely and practical insights from trusted voices across the global bio/pharmaceutical business ecosystem and DCAT Member Companies. Through a variety of engaging formats—including webinars, podcasts, videos, infographics, and reports—The DCAT Pulse brings together fresh perspectives and seasoned expertise, spotlighting trends and opportunities that help DCAT Members stay informed, engaged, and ahead.

Stay tuned for the latest editions of The DCAT Pulse delivered monthly.

The DCAT Pulse: Webinar: The Tariff Outlook & Pharma

Brought to you by the Supply Management Committee.

Evolving US tariff/trade policy remains top of mind for the bio/pharma industry. What may lie ahead in 2026, and what is important to consider in your company’s supply planning? Jens Charlieson, Head of Transport & Trade Compliance at Swedish Orphan Biovitrum AB (Sobi) and Gabriela de Almeida, Managing Director and Partner at Boston Consulting Group, will share key insights.

Member Insights Hub

NOW AVAILABLE TO VIEW

Navigating DCAT Week Video Series

November 2025
Brought to you by the Member Advantage Committee

A nine-part video series to help DCAT Members maximize their experience at DCAT Week, including key tips, session highlights, and membership-enhancing strategies.

LEARN MORE >

NOW AVAILABLE TO LISTEN

Podcast: Transforming Discovery with Jane Liu

December 2025
Brought to you by the Alliance for Industry Women Committee

Explore the mindset and innovation fueling the BRiTeCycle™️ platform as Dr. Jane Liu discusses her path from chemistry professor to biotech CEO.

LEARN MORE >

Available on January 22, 2026

Webinar: The Tariff Outlook & Pharma

January 2026
Brought to you by the Supply Management Committee

Hear expert perspectives on current U.S. tariff policy and what lies ahead in 2026, with practical takeaways for supply planning, cost structure, and pharma manufacturing strategy.

LEARN MORE >